How Credit Genie keeps codebase docs fresh with OpenWiki33m ago Nvidia’s Huang Touts Cybersecurity as Next Big Market for AI37m ago Spain gives WeRide and Uber its first permit for Level 4 self-driving cars43m ago Google brings Gemini for desktop app to Windows49m ago A Quantum Physicist Told His Team 'I Think AGI Is Here.' Here's What Convinced Him49m ago How Chinese AI Firms Tried to Clone U.S. AI Models59m ago IDScan is offering free credit monitoring and ID protection after leaking driver's licenses1h ago Amazon makes its agentic AI platform Quick generally available for desktop on Windows and macOS1h ago The AI Platform Everyone Wants And Nobody Owns1h ago How to watch the Flame Fatales 2026 speedrunning marathon1h ago Ant International, Visa, Mastercard Align on AI Agent Verification Rules1h ago Panic builds over bankrupt Spirit’s looming data sale to Google1h ago Introducing ChatGPT for Financial Services2h ago (Re)introducing Developer Story2h ago

How Credit Genie keeps codebase docs fresh with OpenWiki33m ago Nvidia’s Huang Touts Cybersecurity as Next Big Market for AI37m ago Spain gives WeRide and Uber its first permit for Level 4 self-driving cars43m ago Google brings Gemini for desktop app to Windows49m ago A Quantum Physicist Told His Team 'I Think AGI Is Here.' Here's What Convinced Him49m ago How Chinese AI Firms Tried to Clone U.S. AI Models59m ago IDScan is offering free credit monitoring and ID protection after leaking driver's licenses1h ago Amazon makes its agentic AI platform Quick generally available for desktop on Windows and macOS1h ago The AI Platform Everyone Wants And Nobody Owns1h ago How to watch the Flame Fatales 2026 speedrunning marathon1h ago Ant International, Visa, Mastercard Align on AI Agent Verification Rules1h ago Panic builds over bankrupt Spirit’s looming data sale to Google1h ago Introducing ChatGPT for Financial Services2h ago (Re)introducing Developer Story2h ago

Healthcare Machine Learning4 min reading time

Superluminal Medicines Raises $60M Series B to Advance Obesity Drug

Unite.AIPublished 7 days ago

Superluminal Medicines secured $60M in a Series B round led by BVF Partners to advance its selective MC4R agonist drug for rare genetic obesity into Phase 1 trials by end of 2026. The funding will also expand its GPCR-focused AI-driven drug discovery platform.

#biotechnology #bvf-partners #drug-discovery #mc4r #nvidia #ra-capital-management #superluminal-medicines

More in Healthcare

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources21h ago

Healthcare5 min read

Digital Finance Needs A New Kind Of Identity For AI-Driven Economies

Forbes3h ago

How a researcher uses Codex and ChatGPT to search for new antimicrobial molecules

Open AI News4h ago